... This label is given to medications that should be fast-tracked for research and development and fill an unmet need for situations where no treatment currently exists. It is also being studied for other MDS subtypes.Many people with lower-risk MDS have anemia (low red blood cell counts). ...
... This label is given to medications that should be fast-tracked for research and development and fill an unmet need for situations where no treatment currently exists. It is also being studied for other MDS subtypes.Many people with lower-risk MDS have anemia (low red blood cell counts). ...